Sugi Predict

Sugi Predict / Compounds / SCHEMBL17837277

SCHEMBL17837277

SCHEMBL17837277

COc1n[nH]cc1Nc1nccc(-c2cc3c(s2)C(C)(C)N(CCN2CCOCC2)C3=O)n1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPK3 P27361 1/20 0.69
▸ MAPK1 P28482 1/20 0.69
▸ MKNK2 Q9HBH9 2/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ CCNB2 O95067 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CCNB1 P14635 1/20 0.41
▸ CCNB3 Q8WWL7 1/20 0.41
▸ EIF2AK2 P19525 1/20 0.38
▸ MAP3K14 Q99558 6/20 0.37
▸ SYK P43405 3/20 0.37
▸ ABL1 P00519 3/20 0.37
▸ BCR P11274 3/20 0.37
▸ EGFR P00533 1/20 0.35
▸ MKNK1 Q9BUB5 1/20 0.34
▸ JAK2 O60674 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17856230 0.91 MAPK3 (0.71) MAPK3MAPK1MKNK2FLT3CCNB2
SCHEMBL17856231 0.90 MAPK3 (0.72) MAPK3MAPK1MKNK2FLT3CCNB2
SCHEMBL17856229 0.88 MAPK3 (0.68) MAPK3MAPK1MKNK2FLT3CCNB2
SCHEMBL17856233 0.88 MAPK1 (0.68) MAPK3MAPK1MKNK2FLT3CCNB2
SCHEMBL17856232 0.86 MAPK3 (0.51) MAPK3MAPK1MKNK2FLT3CCNB2
Hydrochloric Acid SCHEMBL17837256 0.85 MAPK3 (0.50) MAPK3MAPK1MKNK2FLT3CCNB2
SCHEMBL17856234 0.85 MAPK3 (0.50) MAPK3MAPK1CDK1CCNB1JAK2
SCHEMBL17837199 0.85 MAPK3 (0.65) MAPK3MAPK1MKNK2FLT3CCNB2
SCHEMBL21965940 0.85 MAPK1 (0.78) MAPK3MAPK1MKNK2FLT3CCNB2
Hydrochloric Acid SCHEMBL17837235 0.85 MAPK3 (0.49) MAPK3MAPK1CDK1CCNB1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE48635-E1 ERK inhibitors ELI LILLY AND COMPANY (US) 2021-07-13 — — US disclosed
EP-3237423-B1 THIENO[2,3-C]PYRROL-4-ONE DERIVATIVES AS ERK INHIBITORS LILLY CO ELI (US) 2019-06-05 — — EP disclosed
EP-3237423-B1 THIENO[2,3-C]PYRROL-4-ONE DERIVATIVES AS ERK INHIBITORS LILLY CO ELI (US) 2019-06-05 — — EP disclosed
US-20160375030-A1 ERK INHIBITORS ELI LILLY AND COMPANY 2016-12-29 — — US disclosed
US-20160375030-A1 ERK INHIBITORS ELI LILLY AND COMPANY 2016-12-29 — — US disclosed
US-9526733-B1 ERK inhibitors ELI LILLY AND COMPANY (US) 2016-12-27 — — US disclosed
US-9526733-B1 ERK inhibitors ELI LILLY AND COMPANY (US) 2016-12-27 — — US disclosed
US-9526733-B1 ERK inhibitors ELI LILLY AND COMPANY (US) 2016-12-27 — — US disclosed
US-9469652-B2 ERK inhibitors ELI LILLY AND COMPANY (US) 2016-10-18 — — US disclosed
US-9469652-B2 ERK inhibitors ELI LILLY AND COMPANY (US) 2016-10-18 — — US disclosed
US-20160176896-A1 ERK INHIBITORS ELI LILLY AND COMPANY 2016-06-23 — — US disclosed
US-20160176896-A1 ERK INHIBITORS ELI LILLY AND COMPANY 2016-06-23 — — US disclosed
US-20160176896-A1 ERK INHIBITORS ELI LILLY AND COMPANY 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160375030-A1 ERK INHIBITORS MAPK4, MAPK1, MAPK3 MAPK3 3/4885MAPK1 2/4885MKNK2 82/4885
US-20160176896-A1 ERK INHIBITORS MAPK4, MAPK1, MAPK3 MAPK3 3/4885MAPK1 2/4885MKNK2 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.